Shu Zheng
- Cancer Research top 0.2%
- MicroRNA in disease regulation 21
- Cancer, Lipids, and Metabolism 17
- Oncology top 0.5%
- Colorectal Cancer Screening and Detection 34
- Colorectal Cancer Treatments and Studies 17
- Molecular Biology top 0.5%
- RNA modifications and cancer 30
- Immunology top 2%
-
- Genetic factors in colorectal cancer 40
-
- Advanced Proteomics Techniques and Applications 21
-
- Gastric Cancer Management and Outcomes 19
- Co-authors
- Jiekai YuSuzhan ZhangXuemin WangLiangliang FanYiding ChenJiaojiao ZhouYingkuan ShaoTing Chen
- Partner nations
- ChinaUnited StatesUnited Kingdom
In The Last Decade
Shu Zheng
361 papers receiving 11.0k citations
Hit Papers
Peers
Comparison fields: 5 of 162
- Cancer Research 3.0k
- Oncology 3.0k
- Molecular Biology 6.1k
- Immunology 1.3k
- Pathology and Forensic Medicine 1.1k
Countries citing papers authored by Shu Zheng
This map shows the geographic impact of Shu Zheng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shu Zheng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shu Zheng more than expected).
Fields of papers citing papers by Shu Zheng
This network shows the impact of papers produced by Shu Zheng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shu Zheng. The network helps show where Shu Zheng may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Shu Zheng, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 1 | |
| 3 | 2024 | 0 | |
| 4 | 2024 | 14 | |
| 5 | 2022 | 5 | |
| 6 | 2021 | 16 | |
| 7 | Application of exosomes as liquid biopsy in clinical diagnosisbreakdown → | 2020 | 510 |
| 8 | 2019 | 11 | |
| 9 | 2019 | 40 | |
| 10 | 2018 | 40 | |
| 11 | 2017 | 10 | |
| 12 | 2016 | 92 | |
| 13 | 2016 | 248 | |
| 14 | 2014 | 302 | |
| 15 | 2012 | 38 | |
| 16 | 2011 | 52 | |
| 17 | 2011 | 151 | |
| 18 | 2011 | 28 | |
| 19 | Veganism does not reduce the risk of the metabolic syndrome in a Taiwanese cohort. | 2011 | 25 |
| 20 | [Effectiveness and safety of preventive usage of liver protective drugs during anti-tuberculosis therapy: a systematic review of clinical trials in China]. | 2010 | 3 |
About Shu Zheng
Shu Zheng is a scholar working on Cancer Research, Oncology and Pathology and Forensic Medicine, having authored 370 papers that have together received 11.2k indexed citations. Recurring topics across this work include Genetic factors in colorectal cancer (40 papers), Colorectal Cancer Screening and Detection (34 papers), RNA modifications and cancer (30 papers), MicroRNA in disease regulation (21 papers), Advanced Proteomics Techniques and Applications (21 papers), Gastric Cancer Management and Outcomes (19 papers), Cancer, Lipids, and Metabolism (17 papers) and Colorectal Cancer Treatments and Studies (17 papers). The work is most often cited by research in Cancer Research (3.0k citations), Oncology (3.0k citations) and Molecular Biology (6.1k citations). Shu Zheng has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Jiekai Yu, Suzhan Zhang, Xuemin Wang, Liangliang Fan, Yiding Chen, Jiaojiao Zhou, Yingkuan Shao, Ting Chen, Kailun Xu and Biting Zhou.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.